Clearmind Medicine Inc. is a pre-clinical pharmaceutical company that focuses on developing innovative psychedelic medicines to help treat health issues that are currently underserved. These health problems include alcohol use disorders, depression, eating disorders, psychotherapy, mental health issues, and other binge behaviors. Originally known as Cyntar Ventures Inc., the company changed its name to Clearmind Medicine Inc. in March 2021 and has been based in Vancouver, Canada since its incorporation in 2017.